|
Market Cap (5-Jun) $28,225,032 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.065 |
52w Low $0.009 |
P/E - |
EPS -0.02 |
RAP released this announcement to the ASX on 11 July 2022, 9:10. The announcement is not marked as price sensitive, and is 1 page(s) in length and 87.61kb in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.801% short sold according to ASIC data. It was ranked the 252nd most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| Medgate Licence Agreement Clarification Announcement | 11 July 2022, 9:10 |
| Medgate extends licence agreement and plans to expand use | 7 July 2022, 9:06 |
| ResApp receives FDA 510(k) clearance for SleepCheckRx | 6 July 2022, 9:26 |
| Cough detection patent granted in Australia and Japan | 5 July 2022, 9:00 |
You must be logged in to post a reply.
ResApp Health 